Real-world clinical outcomes of macrophage activation-like syndrome and hyperferritinemia in sepsis: a retrospective database analysis
Konstantinos Ouranos, Mark Michael, Tilemachos Koutouratsas, Siddharth Das, Evangelia K Mylona, Fadi Shehadeh, Deepa B Gotur, Eleftherios Mylonakis · 2026
Read Real-world clinical outcomes of macrophage activation-like syndrome and hyperferritinemia in sepsis: a retrospective database analysis by Konstantinos Ouranos, Mark Michael, Tilemachos Koutouratsas, Siddharth Das, Evangelia K Mylona, Fadi Shehadeh, Deepa B Gotur, Eleftherios Mylonakis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13272524.txt.
Description
Konstantinos Ouranos leads a 2026 database study of sepsis, a life-threatening response to infection, paired with very high ferritin in the blood. That pattern is called macrophage activation-like syndrome, or MALS. The authors used the TriNetX database and a ferritin cutoff to define the group.
From 2017 to 2025, 10,169 patients met the MALS pattern, against 214,338 without it. After matching, MALS patients died more often at 28 and 90 days and needed breathing tubes, intensive care, and blood pressure drugs more often. Higher ferritin cutoffs meant worse outcomes, and the drug anakinra showed no survival gain.
Catalog record
| CREATOR | Konstantinos Ouranos, Mark Michael, Tilemachos Koutouratsas, Siddharth Das, Evangelia K Mylona, Fadi Shehadeh, Deepa B Gotur, Eleftherios Mylonakis |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46438 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |